Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 13/20 | 0.55 |
| ▸ | BTK | Q06187 | 1/20 | 0.47 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.44 |
| ▸ | CDK19 | Q9BWU1 | 1/20 | 0.44 |
| ▸ | MAP4K1 | Q92918 | 2/20 | 0.43 |
| ▸ | TTK | P33981 | 1/20 | 0.43 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.42 |
| ▸ | MAPK7 | Q13164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29084033 | 0.86 | EGFR (0.49) | EGFRALK | |
| SCHEMBL29084036 | 0.85 | EGFR (0.65) | EGFRBTKALKMAP4K1TTK | |
| SCHEMBL29083968 | 0.83 | ALK (0.44) | EGFRALKMAP4K1LRRK2MAPK7 | |
| SCHEMBL29084102 | 0.83 | EGFR (0.55) | EGFRALK | |
| SCHEMBL29083973 | 0.82 | EGFR (0.62) | EGFRBTKALK | |
| SCHEMBL29084020 | 0.80 | EGFR (0.51) | EGFRBTKLRRK2 | |
| SCHEMBL29084016 | 0.80 | EGFR (0.57) | EGFRALK | |
| SCHEMBL29084096 | 0.80 | EGFR (0.71) | EGFRBTKALKCDK19MAP4K1 | |
| SCHEMBL29084091 | 0.79 | EGFR (0.53) | EGFRALK | |
| SCHEMBL29084107 | 0.78 | EGFR (0.46) | EGFRALKMAP4K1LRRK2MAPK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116670127-A | EGFR inhibitors and compositions and uses thereof | 贝达药业股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2022206797-A1 | EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF | 贝达药业股份有限公司 | 2022-10-06 | — | — | WO | claimed |
| CN-116670127-A | EGFR inhibitors and compositions and uses thereof | 贝达药业股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| WO-2022206797-A1 | EGFR INHIBITOR, AND COMPOSITION AND USE THEREOF | 贝达药业股份有限公司 | 2022-10-06 | — | — | WO | disclosed |